Epstein-Barr viral capsid antigen

Also Known As:
BFRF3, EBV; EB-VCA; EBV capsid antigen; Epstein-Barr capsid antigen; VCA, Epstein-Barr
Networked: 45 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Wu, Yanan: 1 article (01/2013)
2. Zhong, Rugang: 1 article (01/2013)
3. Zeng, Yi: 1 article (01/2013)
4. Zhao, Pengxiang: 1 article (01/2013)
5. Yang, Xinji: 1 article (01/2013)
6. Zhang, Jingxue: 1 article (01/2013)
7. Ma, Jianmin: 1 article (01/2013)
8. Jin, Rui: 1 article (01/2013)
9. Ma, Xuemei: 1 article (01/2013)
10. Cunningham, Philip: 1 article (08/2011)

Related Diseases

1. Infection
2. Epstein-Barr Virus Infections
08/01/1990 - "If IgM to Epstein-Barr viral capsid antigen (EBV VCA) is taken as evidence of current EBV infection, one observer detected 17 of 38 such samples and the other 22 of 38 as acute. "
12/01/2004 - "All patients tested positive for the immunoglobulin (Ig)M antibody against the Epstein-Barr viral capsid antigen, suggesting that a primary Epstein-Barr virus (EBV) infection caused localized facial rash, an alternative clinical picture of GCS."
11/01/2010 - "Additional studies were performed to determine if WA1 IgG reactivity was attributable to polyclonal B-cell activation associated with acute Epstein-Barr virus (EBV) infection; 40 WA1 IgG-positive clinical sera and the 18 WA1 IgG-positive blood donor specimens were all negative for EBV capsid antigen (EBVCA) IgM (a marker of acute EBV infection), and 40 EBVCA IgM-positive sera were all negative for WA1 IgG. These findings indicate that the high WA1 IgG detection rate among clinical specimens does not simply reflect the national WA1 seroprevalence among blood donors or nonspecific reactivity due to acute EBV infection. "
07/01/1994 - "Avidities of EBV capsid antigen-specific IgG (VCA-IgG) and early antigen-specific IgG (EA-IgG) were determined by indirect immunofluorescence during and after acute EBV infection. "
02/01/1982 - "Epstein-Barr viral capsid antigen and nuclear antigen produced by modified procedures were evaluated for use in measuring viral capsid antigen immunoglobulin M and Epstein-Barr virus nuclear antigen antibody responses in sera from patients with suspected Epstein-Barr virus infections. "
3. Infectious Mononucleosis (Glandular Fever)
4. Lymphoma (Lymphomas)
5. Multiple Sclerosis

Related Drugs and Biologics

1. Immunoglobulin G (IgG)
2. Immunoglobulin M (IgM)
3. Antigens
4. Antibodies
5. Urea (Carbamide)
6. Interleukin-2 (IL2)
7. Immunoglobulins (Immunoglobulin)
8. Immunoglobulin D (IgD)
9. Hemagglutinins (Hemagglutinin)
10. Nasopharyngeal carcinoma